Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- News
- Medical Technology specialist joins Research Partnership
Research Partnership
- Live webinar
- The power of a good story: Turn your insights into effective storytelling with data visualisation
Research Partnership
- Article
- How will COVID-19 affect uptake of vaccinations against other diseases?
Research Partnership
- Podcast
- Living With Chronic Illness (Series one)
Research Partnership
- Live webinar
- China: How pharma can maximize success in this rapidly changing emerging market
Research Partnership
- Article
- Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Research Partnership
